We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Information to support laboratories involved with the NHS antenatal and newborn (ANNB) screening programmes with a laboratory component.
Policy and standards for newborn laboratories working with the NHS sickle cell and thalassaemia (SCT) screening programme.
Antenatal maternity services annual standards return 2023 to 24
This guidance explains PHE Screening’s consistent approach to standards across all 11 NHS screening programmes.
This document describes the sickle cell and thalassamia (SCT) screening pathways.
Information for pregnant women to understand what it means to be an alpha zero thalassaemia carrier.
Information for pregnant women to understand what it means to be a delta beta thalassaemia.
Instructions on how to submit key performance indicator (KPI) data for the antenatal and newborn blood spot (NBS) screening programmes.
Requirements for the quality assurance of laboratories providing antenatal and newborn screening services by the United Kingdom Accreditation Service (UKAS).
Statutory guidance to help health professionals provide an inclusive screening programme to all eligible people.
Information and resources for health professionals who provide counselling for people at risk of having a baby with sickle cell disease or thalassaemia.
Template letter for maternity trusts to use for sending screening results to women who miscarry or choose to end their pregnancy.
Information to help healthcare professionals speak with parents at risk of having a child with thalassaemia.
Sickle cell and thalassaemia high/low prevalence laboratory return 2023 to 24
This provides details for screening providers on moving from printed leaflets to digital alternatives.
An overview of the sickle cell and thalassaemia (SCT) screening end-to-end pathway.
These leaflets, in English, French, Bengali and Urdu, can help healthcare professionals speak with people about sickle cell disease.
Information to help healthcare professionals speak with parents at risk of having a child with sickle cell disease.
Information for commissioners and screening providers, to help improve access to screening for people with severe mental illness.
Guidance on using the sickle cell and thalassaemia (SCT) newborn outcomes solution web system.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).